We’re a company focused on tackling some of the toughest health challenges. Our success is reflected in our management team, which is individually and collectively focused on improving the lives of individuals who are faced with debilitating diseases. Members of our management team are leaders in their respective fields, including research, development and commercialization, to name a few.
Executive Leadership for Glenmark Pharmaceuticals, USA
President, North America
Sanjeev Krishan is President of North America business at Glenmark Pharmaceuticals USA and is responsible for its overall operations in the region. He has worked at Glenmark since 2005 and has over 23 years of experience across the Pharmaceuticals value chain.
Prior to Glenmark, he worked for Dr. Reddy’s Laboratories & Reddy Cheminor Inc for nearly eight years where he held several positions of increased responsibilities including management of APIs, Custom synthesis and generic finished dosage business.
He holds a degree in Chemistry from Delhi University, received a Master of Sciences in Biotechnology from the Indian Institute of Technology, Roorkee and completed his MBA in marketing and finance at Symbiosis Institute, Pune.
Senior Vice President, Finance & CFO
Rajeev Sharma is Senior Vice President Finance and CFO at Glenmark Pharmaceuticals Inc., USA and is responsible for the overall finance function for North America region.
He has worked at Glenmark since May 2014 and has over 25 years of work experience in various geographies of the world.
Prior to Glenmark, he worked for Ranbaxy Laboratories for 20 years where he had served positions of Division, Country and Regional finance heads
He holds a Bachelor’s Degree in Commerce from Delhi University and a post-graduate degree in cost and mangement accounting from the Institute of Cost & Works Accountants of India.
Senior Vice President and General Counsel of North America
Laura Lester is Senior Vice President and General Counsel with responsibility for all legal matters in the United States and the global IPM group. She joined Glenmark in October 2020 and has been working with pharmaceutical companies on legal and compliance issues for over 20 years.
Prior to joining Glenmark, Laura was in private practice in Washington DC at Arnold & Porter Kaye Scholer LLP from 2010 to 2020 and Arent Fox LLP from 1997 to 2010. She received a J.D. from Georgetown University Law Center and a B.A. in political science from the University of Missouri.
Senior Vice President & Head – Commercial Operations, US
Dmitrey Kuznetsov is Senior Vice President & Head – Commercial Operations at Glenmark Pharmaceuticals Inc., USA and is responsible for streamlining and driving the commercial operations for the US business, so as to deliver profitable and sustainable growth for Glenmark.
He joined Glenmark in October 2020 and brings experience in the pharmaceutical industry spanning two & a half decades, having moved through multiple roles starting from Pharmaceutical Sales Representative until leading the Generics Business for Sun Pharmaceuticals in US, as the Vice President – Sales & Marketing, Generics in his last assignment. Prior to that, he has held roles of increasing responsibility in leading organizations like HD Smith, McKesson and Eli Lilly. Throughout his career journey, Dmitrey has built an expertise in Pharmaceutical Commercialization, Strategic Sourcing and Supply Chain Management.
He holds a Bachelor’s Degree in Pharmacy from St. Louis College of Pharmacy and a Master’s Degree in Business Administration from Washington University, John M. Olin School of Business.
Our global executive leadership comprises the company’s top decision makers and is representative of the many countries in which we do business. Together, our leadership team is collectively focused on advancing Glenmark’s strategy and objectives. To learn more about our leadership team, click here.